Stocks
Editas Medicine (EDIT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -7.46 | -26.9 | -6.22 | -0.95 | -2.96 | -1.78 | ||
| Changes by years, y/y, % | +15% | +260% | -77% | -85% | +210% | -14.5% | |||
Editas Medicine. EV/EBITDA
Editas Medicine. EV/EBITDA, changes, %
Editas Medicine (EDIT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -0.61 | -0.67 | -1.11 | -3.33 | -1.95 | -1.78 | |
| Changes by years, y/y, % | -87% | -68% | -51% | +240% | +222% | |||
| Changes by quarters, q/q, % | -38% | +11% | +64% | +201% | -41% | |||
